nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjusting conventional FRAX estimates of fracture probability according to the number of prior falls in the preceding year
|
Kanis, John A. |
|
|
34 |
3 |
p. 479-487 |
artikel |
2 |
Are there specific clinical risk factors for the occurrence of multiple fractures? The FRISBEE study
|
Charles, A. |
|
|
34 |
3 |
p. 501-506 |
artikel |
3 |
A summary of the Russian clinical guidelines on the diagnosis and treatment of osteoporosis
|
Belaya, Zhanna |
|
|
34 |
3 |
p. 429-447 |
artikel |
4 |
A 3-year retrospective analysis of patients admitted with clinical vertebral fragility fractures across hospitals in England, UK
|
Tan, Chia Wei |
|
|
34 |
3 |
p. 607-611 |
artikel |
5 |
Baseline serum PINP level is associated with the increase in hip bone mineral density seen with Romosozumab treatment in previously untreated women with osteoporosis
|
Kashii, Masafumi |
|
|
34 |
3 |
p. 563-572 |
artikel |
6 |
Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study
|
Tutaworn, Teerapat |
|
|
34 |
3 |
p. 573-584 |
artikel |
7 |
Changes in RANKL and TRAcP 5b after discontinuation of denosumab suggest RANKL mediated formation of osteoclasts results in the increased bone resorption
|
Sølling, Anne Sophie |
|
|
34 |
3 |
p. 599-605 |
artikel |
8 |
Comments to “No impact of anti-Rank ligand and PTH analogs on cardiovascular risk in postmenopausal osteoporosis: a systematic literature review and meta-analysis”
|
Yang, Shuman |
|
|
34 |
3 |
p. 617-623 |
artikel |
9 |
Correction to: Nonoperative versus operative management of frail institutionalized older patients with a proximal femoral fracture: a cost-utility analysis alongside a multicenter prospective cohort study
|
Loggers, S. A. I. |
|
|
34 |
3 |
p. 625-626 |
artikel |
10 |
C-reactive protein predicts endocortical expansion but not fracture in older men: the prospective STRAMBO study
|
Girard, Dylan |
|
|
34 |
3 |
p. 539-550 |
artikel |
11 |
Epidemiology of pelvic and acetabular fractures in the USA from 2007 to 2014
|
Alvarez-Nebreda, Maria Loreto |
|
|
34 |
3 |
p. 527-537 |
artikel |
12 |
Fracture risk and assessment in adults with cancer
|
Ye, Carrie |
|
|
34 |
3 |
p. 449-466 |
artikel |
13 |
Impact of the COVID-19 pandemic on osteoporotic hip fractures among outpatients in Germany
|
Kostev, Karel |
|
|
34 |
3 |
p. 615-616 |
artikel |
14 |
Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice
|
Kravvariti, Evrydiki |
|
|
34 |
3 |
p. 585-598 |
artikel |
15 |
Nonoperative versus operative management of frail institutionalized older patients with a proximal femoral fracture: a cost-utility analysis alongside a multicenter prospective cohort study
|
Loggers, S. A. I. |
|
|
34 |
3 |
p. 515-525 |
artikel |
16 |
Prevalence of low bone mineral density (T-score ≤ − 2.5) in the whole spectrum of chronic kidney disease: a systematic review and meta-analysis
|
Duarte, Marvery P. |
|
|
34 |
3 |
p. 467-477 |
artikel |
17 |
Prevalence of osteoporosis in older male veterans receiving hip-containing computed tomography scans: opportunistic use of biomechanical computed tomography analysis (BCT)
|
Teng, Polly F. |
|
|
34 |
3 |
p. 551-561 |
artikel |
18 |
Primary hyperparathyroidism and fracture probability
|
Kanis, John A. |
|
|
34 |
3 |
p. 489-499 |
artikel |
19 |
The causal association of sarcopenia with osteoporosis and obesity: a Mendelian randomization analysis
|
Ran, Shu |
|
|
34 |
3 |
p. 613-614 |
artikel |
20 |
The high-risk hip fracture patient and the palliative care consult
|
Schlauch, Adam M. |
|
|
34 |
3 |
p. 507-513 |
artikel |